In this study, we aim to assess the expression of CD4 and CD8 as T cell markers and macrophage markers (CD68 for M1, MMP9 for M2) in cases of DLBCL and correlate the expression to other clinicopathologic features and clinical outcomes. The gene discussed is CD8A; the disease is diffuse large B-cell lymphoma.